EUVIMEDEUVIMED entdecken
Crossref

Advances in Transfusion Medicine

Debra Nordmeyer, John E. Forestner, Michael H. Wall

Advances in Anesthesia · 2007

DOI: 10.1016/j.aan.2007.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Anesthesia, 2007. Verfasst von Debra Nordmeyer und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transfusion medicine has developed as a specialty by linking rapidly evolving knowledge in areas of physiology and immunology to the vastly expanded clinical requirements for blood products resulting from advances in medicine and surgery. This article covers major developments in transfusion medicine related to anesthesiology and surgery. It will familiarize the anesthesia practitioner with evolving concepts in basic science as they relate to innovations in clinical care in three areas: (1) red cell transfusion, (2) other blood components, and (3) recently introduced massive transfusion protocols. RED BLOOD CELL TRANSFUSION Blood component therapy is a limited resource that contributes to overall health care expense. In the United States, four million patients will receive 12 million units of packed red blood cells this year. The estimated hospital cost for a unit of autologous blood ranges from $250 to $750. Actual costs of transfusion therapy, alternatives to transfusion therapy, complications associated with transfusion therapy, and complications associated with anemia are unknown [1]. The Transfusion Requirement in Critical Care trial has shown that a conservative strategy of red blood cell transfusion (transfusion for a hemoglobin of less than 7 g/dL) is as effective, if not superior to, a liberal transfusion strategy (transfusion for a hemoglobin less than 9 g/dL) in normovolemic critically ill patients [2]. Following a conservative transfusion strategy, institutions may decrease costs by limiting perioperative erythrocyte transfusions and their complications [2]. Erythrocytes compose an estimated 25 trillion of the 100 trillion cells that are found in the human body [3]. The major function of the erythrocyte is to transport hemoglobin, which in turn carries oxygen from the lungs to the tissues. Along with oxygen transporting capacity, hemoglobin acts as an acid–base buffer. The buffering capacity of hemoglobin provides about 70% of the buffering capacity of whole blood. Red blood cells also remove carbon dioxide from the body by using carbonic anhydrase, an enzyme that catalyzes

Zitieren

APA

Nordmeyer, D., Forestner, J. E., & Wall, M. H. (2007). Advances in Transfusion Medicine. Advances in Anesthesia. https://doi.org/10.1016/j.aan.2007.07.005

Vancouver

Nordmeyer D, Forestner JE, Wall MH. Advances in Transfusion Medicine. Advances in Anesthesia. 2007. doi:10.1016/j.aan.2007.07.005

BibTeX
@article{Nordmeyer2007,
  author = {Nordmeyer, Debra and Forestner, John E. and Wall, Michael H.},
  title = {Advances in Transfusion Medicine},
  journal = {Advances in Anesthesia},
  year = {2007},
  doi = {10.1016/j.aan.2007.07.005}
}
Kostenlos starten →